B-RAF with PLX4032

From Proteopedia

Revision as of 18:14, 7 October 2010 by Jens Hemmingsen (Talk | contribs)
Jump to: navigation, search

B-RAF with PLX4032

PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.


testcaption

Drag the structure with the mouse to rotate











Proteopedia Page Contributors and Editors (what is this?)

J.D. Woodruff, Jens Hemmingsen, Michal Harel

Retrieved from "http://52.214.119.220/wiki/index.php/B-RAF_with_PLX4032"
Personal tools